Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
+854K
-
Total reported value, excl. options
-
$1.85B
-
Value change
-
+$18.3M
-
Put/Call ratio
-
1.21
-
Number of buys
-
90
-
Number of sells
-
-51
-
Price
-
$36.34
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q1 2022
166 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q1 2022.
Legend Biotech Corp - COMMON STOCK (LEGN) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
of 367M outstanding shares and own 13.89% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (6.94M shares), BlackRock Inc. (3.05M shares), Capital International Investors (2.81M shares), WELLINGTON MANAGEMENT GROUP LLP (2.61M shares), FMR LLC (2.42M shares), Capital World Investors (2.21M shares), FEDERATED HERMES, INC. (2.11M shares), ALLIANCEBERNSTEIN L.P. (2.08M shares), BAKER BROS. ADVISORS LP (2.01M shares), and Artisan Partners Limited Partnership (1.78M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.